| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |